Cargando…
Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients
BACKGROUND: Parameters of body composition have prognostic potential in patients with oncologic diseases. The aim of the present study was to analyse the prognostic potential of radiomics‐based parameters of the skeletal musculature and adipose tissues in patients with advanced hepatocellular carcin...
Autores principales: | Saalfeld, Sylvia, Kreher, Robert, Hille, Georg, Niemann, Uli, Hinnerichs, Mattes, Öcal, Osman, Schütte, Kerstin, Zech, Christoph J., Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Verslype, Chris, Gebauer, Bernhard, Sengel, Christian, Bargellini, Irene, Iezzi, Roberto, Berg, Thomas, Klümpen, Heinz J., Benckert, Julia, Gasbarrini, Antonio, Amthauer, Holger, Sangro, Bruno, Malfertheiner, Peter, Preim, Bernhard, Ricke, Jens, Seidensticker, Max, Pech, Maciej, Surov, Alexey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570090/ https://www.ncbi.nlm.nih.gov/pubmed/37592827 http://dx.doi.org/10.1002/jcsm.13315 |
Ejemplares similares
-
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
por: Surov, Alexey, et al.
Publicado: (2023) -
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
por: Öcal, Osman, et al.
Publicado: (2022) -
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
por: Öcal, Osman, et al.
Publicado: (2022) -
Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021) -
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
por: Öcal, Osman, et al.
Publicado: (2021)